Legal & General Group
BEAT

Legal & General Group’s BioTelemetry, Inc. BEAT Stock Holding History

Legal & General Group’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-357,487
Closed -$25.8M – 3551
2020
Q4 		$25.8M Sell
357,487
-17,787
-5% -$931K 0.01% 775
2020
Q3 		$17.1M Buy
375,274
+75,584
+25% +$3.16M 0.01% 836
2020
Q2 		$13.5M Buy
299,690
+16,200
+6% +$726K 0.01% 886
2020
Q1 		$12.4M Buy
283,490
+5,803
+2% +$267K 0.01% 848
2019
Q4 		$12.7M Sell
277,687
-25,789
-8% -$1.12M 0.01% 931
2019
Q3 		$11.8M Buy
303,476
+32,450
+12% +$1.4M 0.01% 924
2019
Q2 		$13.1M Buy
271,026
+50,768
+23% +$2.67M 0.01% 899
2019
Q1 		$13.7M Buy
220,258
+759
+0.3% +$52.1K 0.01% 819
2018
Q4 		$13.1M Buy
219,499
+149,453
+213% +$8.97M 0.01% 780
2018
Q3 		$4.49M Buy
70,046
+8,060
+13% +$450K ﹤0.01% 1244
2018
Q2 		$2.8M Buy
61,986
+4,245
+7% +$169K ﹤0.01% 1486
2018
Q1 		$1.78M Buy
57,741
+1,653
+3% +$54.4K ﹤0.01% 1676
2017
Q4 		$1.68M Buy
56,088
+585
+1% +$16.9K ﹤0.01% 1691
2017
Q3 		$1.83M Buy
55,503
+3,385
+6% +$117K ﹤0.01% 1628
2017
Q2 		$1.74M Buy
52,118
+5,139
+11% +$153K ﹤0.01% 1604
2017
Q1 		$1.36M Buy
46,979
+107
+0.2% +$2.65K ﹤0.01% 1672
2016
Q4 		$1.05M Buy
46,872
+21,931
+88% +$429K ﹤0.01% 1721
2016
Q3 		$463K Buy
24,941
+20,255
+432% +$382K ﹤0.01% 1730
2016
Q2 		$75K Buy
4,686
+664
+17% +$9.77K ﹤0.01% 2262
2016
Q1 		$48K Buy
4,022
+1,632
+68% +$18.2K ﹤0.01% 2438
2015
Q4 		$28K Hold
2,390
– – ﹤0.01% 2660
2015
Q3 		$28K Hold
2,390
– – ﹤0.01% 2663
2015
Q2 		$22K Hold
2,390
– – ﹤0.01% 2718
2015
Q1 		$21K Buy
+2,390
New +$24.1K ﹤0.01% 2721

Other funds holding BEAT

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Legal & General Group's BEAT Position: Q1 2021 in Review

Legal & General Group sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 357,487 shares — an estimated $25.8M sold.

Legal & General Group first reported a position in BEAT in Q1 2015 and held it in 24 quarters. The position peaked at $25.8M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Legal & General Group reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Legal & General Group sold 357,487 BioTelemetry, Inc. shares in Q1 2021, an estimated $25.8M.
  • Legal & General Group first reported a position in BioTelemetry, Inc. in Q1 2015 and held it in 24 quarters.
  • Legal & General Group's BioTelemetry, Inc. position peaked at $25.8M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Legal & General Group's 13F filing for Q1 2021, filed 17 May 2021.